Shanxi Luliang Chinese Medicine Factory

Shanxi Luliang Chinese Medicine Factory (山西省吕梁中药厂) is a state-owned pharmaceutical manufacturer founded in 1992 and based in Luliang, Shanxi Province, China. The company specializes in the research, development, production, and sale of traditional Chinese medicines (TCM), including tablets, hard capsules, granules, pills, and Chinese herbal pieces. It holds 105 drug production approvals, covering both Chinese patent medicines and chemical drugs, with notable products such as Changchunbao Pills, Jiuzhi Qingxin Pills, Kaiguang Fuming Pills, and Gushen Shengfa Pills. In mid-2025, the company entered bankruptcy reorganization under the supervision of the Luliang City Intermediate People's Court, and its administrator has been actively recruiting restructuring investors to revitalize its valuable drug portfolio and manufacturing assets.